Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Long-term potentiation (LTP) in the dentate gyrus was previously shown to be enhanced by nicotine, an effect dependent on both homomeric α7 and heteromeric α2β2 nicotinic acetylcholine receptors (nAChR). In our experiments, bath-applied nicotine produced no significant enhancement of LTP. The α7 nAChR silent agonist NS6740, a weak activator of α7 nAChR ion channels but an effective modulator of the cholinergic anti-inflammatory pathway, decreased LTP and, additionally, produced a substantial reduction in the baseline synaptic function prior to the high frequency stimulation used to induce LTP. The effects of NS6740 on the various ligand-gated ion channels associated with the generation and modulation of dentate LTP were evaluated with receptors expressed in Xenopus oocytes. A 60 s pre-application of 5 μM NS6740 to α7 receptors blocked the response to subsequent applications of acetylcholine (ACh). In contrast, the responses of α2β2 nAChR to control applications of ACh were not significantly affected by NS6740. Likewise, responses of cells expressing GluR1 + GluR2 AMPA-type glutamate receptor subunits or GABAA α1, β2, and γ2L subunits to control agonist applications (100 μM kainic acid or 10 μM GABA, respectively), were unaffected by NS6740. The effects of NS6740 on α7 were inconsistent with simple antagonism since, while unresponsive to ACh, the receptors exposed to NS6740 were effectively activated by the positive allosteric modulator PNU-120596. The results support the hypothesis that NS6740 switches the mode of α7 signaling in a channel-independent manner that can reduce synaptic function.
???displayArticle.pubmedLink???
29679680 ???displayArticle.pmcLink???PMC6191859 ???displayArticle.link???Neurosci Lett ???displayArticle.grants???[+]
Abbas,
The α7 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal IκB and CD11b gene expression in mice.
2017, Pubmed
Abbas,
The α7 nicotinic acetylcholine receptor positive allosteric modulator attenuates lipopolysaccharide-induced activation of hippocampal IκB and CD11b gene expression in mice.
2017,
Pubmed Arendash,
Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21.
1995,
Pubmed Azuma,
Metabolism and disposition of GTS-21, a novel drug for Alzheimer's disease.
1999,
Pubmed Bagdas,
New Insights on Neuronal Nicotinic Acetylcholine Receptors as Targets for Pain and Inflammation: A Focus on α7 nAChRs.
2018,
Pubmed Boess,
The novel alpha7 nicotinic acetylcholine receptor agonist N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-7-[2-(methoxy)phenyl]-1-benzofuran-2-carboxamide improves working and recognition memory in rodents.
2007,
Pubmed
,
Xenbase Borovikova,
Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.
2000,
Pubmed Briggs,
Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
2009,
Pubmed
,
Xenbase Briggs,
Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.
1997,
Pubmed Bruchfeld,
Whole blood cytokine attenuation by cholinergic agonists ex vivo and relationship to vagus nerve activity in rheumatoid arthritis.
2010,
Pubmed Campo-Soria,
Mechanism of action of benzodiazepines on GABAA receptors.
2006,
Pubmed
,
Xenbase Chatterjee,
Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation.
2009,
Pubmed Chojnacka,
Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor.
2013,
Pubmed
,
Xenbase D'Andrea,
Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons.
2006,
Pubmed de Jonge,
The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation.
2007,
Pubmed Donvito,
The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.
2017,
Pubmed Fabian-Fine,
Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus.
2001,
Pubmed Freitas,
The antinociceptive effects of nicotinic receptors α7-positive allosteric modulators in murine acute and tonic pain models.
2013,
Pubmed Girod,
Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors.
2000,
Pubmed Halevi,
Conservation within the RIC-3 gene family. Effectors of mammalian nicotinic acetylcholine receptor expression.
2003,
Pubmed
,
Xenbase Hollmann,
Ca2+ permeability of KA-AMPA--gated glutamate receptor channels depends on subunit composition.
1991,
Pubmed
,
Xenbase Horenstein,
Multiple pharmacophores for the selective activation of nicotinic alpha7-type acetylcholine receptors.
2008,
Pubmed
,
Xenbase Hu,
Attenuation of Collagen-Induced Arthritis in rat by nicotinic alpha7 receptor partial agonist GTS-21.
2014,
Pubmed Kem,
The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21).
2000,
Pubmed Kem,
Pharmacokinetic Limitations on Effects of an Alpha7-Nicotinic Receptor Agonist in Schizophrenia: Randomized Trial with an Extended-Release Formulation.
2018,
Pubmed Kox,
GTS-21 inhibits pro-inflammatory cytokine release independent of the Toll-like receptor stimulated via a transcriptional mechanism involving JAK2 activation.
2009,
Pubmed Lee,
More than a pore: ion channel signaling complexes.
2014,
Pubmed Levin,
Nicotinic effects on cognitive function: behavioral characterization, pharmacological specification, and anatomic localization.
2006,
Pubmed Lynch,
Long-term potentiation and memory.
2004,
Pubmed Mulcahy,
Resistance to Inhibitors of Cholinesterase 3 (Ric-3) Expression Promotes Selective Protein Associations with the Human α7-Nicotinic Acetylcholine Receptor Interactome.
2015,
Pubmed Nakauchi,
Endogenously released ACh and exogenous nicotine differentially facilitate long-term potentiation induction in the hippocampal CA1 region of mice.
2012,
Pubmed Nakauchi,
Nicotine gates long-term potentiation in the hippocampal CA1 region via the activation of alpha2* nicotinic ACh receptors.
2007,
Pubmed Papke,
The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.
2015,
Pubmed
,
Xenbase Papke,
The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.
2014,
Pubmed
,
Xenbase Papke,
The minimal pharmacophore for silent agonism of the α7 nicotinic acetylcholine receptor.
2014,
Pubmed
,
Xenbase Papke,
Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.
2018,
Pubmed
,
Xenbase Papke,
Activation and desensitization of nicotinic alpha7-type acetylcholine receptors by benzylidene anabaseines and nicotine.
2009,
Pubmed
,
Xenbase Papke,
Comparative pharmacology of rat and human alpha7 nAChR conducted with net charge analysis.
2002,
Pubmed
,
Xenbase Papke,
Working with OpusXpress: methods for high volume oocyte experiments.
2010,
Pubmed
,
Xenbase Papke,
Similar activity of mecamylamine stereoisomers in vitro and in vivo.
2013,
Pubmed
,
Xenbase Papke,
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists.
2011,
Pubmed
,
Xenbase Pastalkova,
Storage of spatial information by the maintenance mechanism of LTP.
2006,
Pubmed Paulo,
Proteomic analysis of an alpha7 nicotinic acetylcholine receptor interactome.
2009,
Pubmed Pavlov,
Selective alpha7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis.
2007,
Pubmed Pieschl,
Effects of BMS-902483, an α7 nicotinic acetylcholine receptor partial agonist, on cognition and sensory gating in relation to receptor occupancy in rodents.
2017,
Pubmed Prickaerts,
EVP-6124, a novel and selective α7 nicotinic acetylcholine receptor partial agonist, improves memory performance by potentiating the acetylcholine response of α7 nicotinic acetylcholine receptors.
2012,
Pubmed Rosas-Ballina,
Cholinergic control of inflammation.
2009,
Pubmed Rosas-Ballina,
The selective alpha7 agonist GTS-21 attenuates cytokine production in human whole blood and human monocytes activated by ligands for TLR2, TLR3, TLR4, TLR9, and RAGE.
2009,
Pubmed Sigurdsson,
Long-term potentiation in the amygdala: a cellular mechanism of fear learning and memory.
2007,
Pubmed Skok,
Editorial: To channel or not to channel? Functioning of nicotinic acetylcholine receptors in leukocytes.
2009,
Pubmed Stokes,
Looking below the surface of nicotinic acetylcholine receptors.
2015,
Pubmed Tatsumi,
Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.
2005,
Pubmed Thomsen,
The α7 nicotinic acetylcholine receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce lipopolysaccharide-induced TNF-α release from microglia.
2012,
Pubmed Tietje,
Preclinical characterization of A-582941: a novel alpha7 neuronal nicotinic receptor agonist with broad spectrum cognition-enhancing properties.
2008,
Pubmed Valbuena,
Non-canonical Signaling, the Hidden Life of Ligand-Gated Ion Channels.
2016,
Pubmed Van Kampen,
AR-R 17779 improves social recognition in rats by activation of nicotinic alpha7 receptors.
2004,
Pubmed van Maanen,
Two novel α7 nicotinic acetylcholine receptor ligands: in vitro properties and their efficacy in collagen-induced arthritis in mice.
2015,
Pubmed
,
Xenbase van Westerloo,
The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice.
2006,
Pubmed Wang,
Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation.
2003,
Pubmed Welsby,
Nicotinic receptor-mediated enhancement of long-term potentiation involves activation of metabotropic glutamate receptors and ryanodine-sensitive calcium stores in the dentate gyrus.
2006,
Pubmed Whitlock,
Learning induces long-term potentiation in the hippocampus.
2006,
Pubmed Williams,
Intrinsically low open probability of α7 nicotinic acetylcholine receptors can be overcome by positive allosteric modulation and serum factors leading to the generation of excitotoxic currents at physiological temperatures.
2012,
Pubmed
,
Xenbase Wu,
GTS-21, an α7-nicotinic acetylcholine receptor agonist, modulates Th1 differentiation in CD4+ T cells from patients with rheumatoid arthritis.
2014,
Pubmed Yue,
GTS-21 attenuates lipopolysaccharide-induced inflammatory cytokine production in vitro by modulating the Akt and NF-κB signaling pathway through the α7 nicotinic acetylcholine receptor.
2015,
Pubmed
